Pharmacists play an important role in helping to prevent adverse drug events (ADEs) related to opioids. That’s why ODPHP has partnered with the American Pharmacists Association (APhA) to offer free continuing pharmacy education (CPE) credit for Pathways to Safer Opioid Use, our interactive training on the safe use of opioids to manage chronic pain.…

There are around 4 million births per year in the United States. Several hundred thousand of these infants are admitted to Neonatal Intensive Care Units (NICUs) annually because of a national prematurity rate of 9.6%, as well as 2-3% rate of congenital anomalies.  
Thursday, September 28 | 2:00 p.m. – 3:00 p.m. ET | Register Now

We’re pleased to invite you to join ODPHP for a webinar about reducing the rates of adverse drug events.

Adverse drug events (ADEs) are injuries caused by medical interventions related to a pharmaceutical drug. They include medication errors, adverse drug reactions, allergic reactions, and overdoses.…

The importance of seasonal influenza vaccine for health care workers and high risk groups has been well documented, yet health care worker (HCW) influenza vaccination rates have risen only minimally over the past 20 years and are far short of U.S. Department of Health and Human Services Healthy People 2020 goals whose target is a 90 percent vaccination rate. One of the fundamental tenets of health care is to care for patients while protecting ourselves from harm. Because HCWs work in an environment where frequent contact with infectious patients is routine, we are at risk for exposure to influenza with possible transmission to other patients, their families, and other HCWs. The situation calls for a review of attitudes and beliefs toward influenza vaccination with a focus on the successful strategies associated with increased HCW vaccination rates.

The National Institute on Drug Abuse (NIDA) has recently updated the NIDAMED Web Portal, which includes science-based information for health professionals on the causes and consequences of drug use and addiction.

The updated NIDAMED portal supports the goals of the National Action Plan for Adverse Drug Event Prevention which is to support training methods, interventions, and tools to encourage, model, and facilitate safe opioid prescribing.…

September 12, 2017 9:00 a.m. – 4:00 p.m. ET | Register

The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff, is hosting a one day public workshop entitled “Reducing the Risk of Preventable Adverse Drug Events Associated with Hypoglycemia in the Older Population.” During the workshop, public and federal partners will discuss:

The importance of individualizing glycemic control targets for older patients with diabetes Risk reduction for serious hypoglycemia Medication safety efforts, both those that are a part of FDA’s Safe Use Initiative and those external to the FDA, that are relevant and important to older adults living with diabetes Future areas of research

The National Action Plan for Adverse Drug Event Prevention identifies hypoglycemia as a common, clinically significant, and preventable adverse effect from diabetes agents that can cause serious harm to patients.…

Health care-associated infections (HAIs) are infections people get while receiving care for another condition. HAIs are a significant cause of illness and death, affecting about 1 in 25 Americans who receive hospital care. To address the problem of HAIs, the U.S. Department of Health and Human Services (HHS) released the National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination (HAI Action Plan) in 2009.…

Stroke takes a serious toll on the health of Americans: Every 40 seconds, someone in the United States has a stroke. Every 4 minutes, someone dies of a stroke. All health care providers — physicians, nurses, pharmacists, and others — play an important role in preventing this deadly disease. And May, as National Stroke Awareness Month, is the perfect time to reflect on what each of us can do to prevent, detect, and treat stroke.
Representatives from more than 20 federal departments, agencies, and offices worked under the coordination of the HHS Office of HIV/AIDS and Infectious Disease Policy to update the National Viral Hepatitis Action Plan, 2017 – 2020. The Action Plan provides a strategic framework to work collaboratively across diverse sectors to achieve four key goals: 1) Prevent new hepatitis B and C infections, 2) reduce deaths and improve the health of people living with viral hepatitis, 3) reduce viral hepatitis health disparities, and 4) coordinate, monitor and report on implementation and viral hepatitis activities. The Action Plan identifies strategies and recommended actions to help focus and guide the efforts of federal, state, tribal, county, city and organizational partners and indicators to track the progress in achieving these goals. In addition, the Action Plan includes 19 indicators to promote transparency and accountability for results and movement toward the 2020 goals.

This webinar is in the past. To get more information:

Watch the webinar Download the questions and answers

March 24, 2017, 1 p.m. – 2 p.m. ET  |  Register Now

We’re pleased to invite you to join the Office of Disease Prevention and Health Promotion, PFCC partners, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Centers for Medicare and Medicaid Services for a webinar about health care-associated infections (HAIs).…